# Nested Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nested-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.nestedtx.com
- Total disclosed funding: $50M
- Latest round: Series A (Apr 21, 2022)
- Investors on record: 6

## About

Founded in 2021 by Klaus Hoeflich, Kevan Shokat, and Arvin Dar, and based in Massachusetts, US, Nested Therapeutics, Inc. operates as a biotech company that develops medicines for cancer treatment. In April 2022, Nested Therapeutics, Inc. raised USD 50 million in series A funding led by Goldman Sachs Asset Management, with participation from Avidity Partners, Cowen Investment Management, Foresite Capital, Versant Ventures, and Section 32. As of 2022, the company is being led by Darrin Miles as its CEO. 

In April 2022, Nested Therapeutics, Inc. raised USD 50 million in series A funding led by new investor Goldman Sachs Asset Management, with participation from new investors Avidity Partners, Cowen Investment Management, Foresite Capital, Versant Ventures, and Section 32.

The firm leverages genomics, computational biophysics, machine learning, and chemical biology to tap mutational clusters and offers a drug discovery platform that creates precision medicines to treat cancers and tumors.

The company intends to use the October 2022 funding to accelerate its pipeline and expand the reach of precision medicine.

## Funding rounds

- Series A, Apr 21, 2022, $50M — Versant Ventures, Goldman Sachs Asset Management, Foresite Capital, Cowen Investment Management, Section 32, Avidity Partners

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series A
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series A
- Cowen Investment Management — Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A
- Avidity Partners — Series A